If your cholesterol test came back higher than ever during pregnancy, take a breath. In the vast majority of cases, this isn't a new health problem, it's your body doing exactly what it's supposed to do.
Why Cholesterol Rises So Much During Pregnancy
Pregnancy triggers a cascade of hormonal changes, including a significant rise in estrogen, that ramps up your liver's cholesterol and LDL production. This isn't a malfunction, it's purpose-built. Cholesterol is a essential building block for cell membranes and hormones, and your growing baby needs a steady supply of it for normal development.
The numbers involved are genuinely striking. Research tracking lipid levels through pregnancy found total cholesterol and LDL typically rise by roughly 25 to 30 percent, while triglycerides can more than double, increasing by over 100 percent in some cases. Interestingly, HDL doesn't show the same dramatic shift. The good news: for the overwhelming majority of women, all of this reverses on its own, with lipid levels generally returning to normal within 3 to 6 months after delivery.
When Something Actually Needs Attention
For most pregnant women, no cholesterol treatment is needed at all, this is simply monitored and left alone. The main exception is familial hypercholesterolemia (FH), the inherited condition we've covered separately, where LDL is already elevated well before pregnancy and the additional pregnancy-related rise stacks on top of an already high baseline.
Why Statins Are Off the Table (Mostly)
This is where things get more nuanced than a simple yes or no. Statins, the medication we've covered in detail elsewhere, have long been classified as contraindicated during pregnancy, and standard guidance remains to stop them as soon as pregnancy is confirmed or suspected.
That said, the picture has shifted slightly in recent years. In 2021, the FDA removed its strongest warning against statin use during pregnancy, opening the door to individualized decisions for women at very high cardiovascular risk. This shift has mainly affected discussions around FH specifically, where a small body of research following statin use in high-risk pregnancies hasn't shown a clear increase in complications. Even so, this remains a specialist-guided exception, not a general recommendation, and the standard advice for the vast majority of pregnant women is still to pause statin therapy entirely.
When treatment genuinely can't wait, bile acid sequestrants are currently the only class of cholesterol medication officially approved for use during pregnancy, largely because they aren't absorbed into the bloodstream and therefore can't reach the fetus. Ezetimibe and fenofibrate are sometimes considered case by case when the potential benefit outweighs the uncertainty, but they aren't first-line options.
A Detail Our Editorial Team Found Worth Flagging
While researching this topic, our editorial team came across something that connects directly to an article we wrote earlier on red yeast rice. We had originally covered that supplement mainly through the lens of it functioning as an unregulated statin. Looking into pregnancy safety specifically brought a different angle into focus: pregnant women may reasonably assume a "natural" supplement carries less risk than a prescription drug, when in this specific case, the opposite concern applies. If red yeast rice contains meaningful levels of monacolin K, it's pharmacologically behaving like the exact medication that's supposed to be avoided during pregnancy, just without a doctor's oversight, a consistent dose, or any pregnancy-specific safety testing behind it. This is a case where the "natural equals safer" assumption could be particularly misleading.
Quick Reference
| Situation | Typical Approach |
|---|---|
| Normal pregnancy, no prior cholesterol issues | No treatment, routine monitoring only |
| Familial hypercholesterolemia (FH) | Individualized specialist care, statins occasionally considered in select high-risk cases |
| Treatment genuinely needed | Bile acid sequestrants (only officially approved option) |
| Red yeast rice or similar supplements | Avoid, functions as an unregulated statin |
Frequently Asked Questions
Q: Should I be worried if my cholesterol looks "high" on a normal pregnancy lipid panel?
Generally not, since standard non-pregnant reference ranges don't apply the same way during pregnancy. Your obstetric provider interprets these numbers in that specific context, so a number that would concern you outside of pregnancy often isn't flagged during it.
Q: I was on a statin before getting pregnant. What should I do?
This is a conversation to have with your doctor as soon as pregnancy is confirmed or being planned, rather than something to decide alone. Standard guidance is to stop, though your specific situation, especially if you have FH, may warrant a more individualized discussion.
Q: Can diet and exercise meaningfully lower cholesterol during pregnancy?
They're still worth maintaining for overall health, but they won't meaningfully counteract the hormonally driven rise in cholesterol that's a normal part of pregnancy. This isn't the same kind of cholesterol elevation that responds to lifestyle changes the way it might outside of pregnancy.
Key Takeaway
A significant rise in cholesterol during pregnancy, often 25 to 30 percent for LDL and considerably more for triglycerides, is a normal, expected part of supporting fetal development, and it typically resolves within months of delivery without any treatment. The main exception is familial hypercholesterolemia, where care becomes more individualized. Statins remain generally avoided during pregnancy despite some recent softening in FDA guidance, and if treatment is truly necessary, bile acid sequestrants are the standard first choice. Perhaps most importantly, this is exactly the situation where an unregulated supplement like red yeast rice deserves more caution, not less, than a properly monitored prescription medication.
References
- Lewek J, Bielecka-Dąbrowa A, Toth PP, Banach M. Dyslipidaemia Management in Pregnant Patients: A 2024 Update. European Heart Journal Open. 2024;4(3):oeae032. doi.org/10.1093/ehjopen/oeae032
- Patel N, Mittal N, Wilkinson MJ, Taub PR. Unique Features of Dyslipidemia in Women Across a Lifetime and a Tailored Approach to Management. American Journal of Preventive Cardiology. 2024;18:100666. doi.org/10.1016/j.ajpc.2024.100666
- U.S. Food and Drug Administration. FDA Requests Removal of Strongest Warning Against Using Cholesterol-Lowering Statins During Pregnancy. 2021. fda.gov/drugs/drug-safety-and-availability/fda-requests-removal-strongest-warning-against-using-cholesterol-lowering-statins-during-pregnancy